Sanofi

SAN · Euronext Paris · EUR

€73.10+0.63%+€0.46

Close · October 1, 2026

At a glance

Revenue growth: +5.49%; 2025 vs 2024
Net income growth: +40.52%; 2025 vs 2024
Net margin: 16.7%; 2024: 12.6%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	46,716	44,286	41,109	40,304	39,175	37,369	37,631	35,677	36,221	34,696
Cost of revenue	12,923	13,195	12,619	11,869	12,251	12,106	11,976	11,321	11,447	10,701
Gross profit	33,793	31,091	28,490	28,435	26,924	25,263	25,655	24,356	24,774	23,995
Selling, general and administrative	9,616	9,247	9,003	8,785	9,599	9,448	9,967	9,934	10,164	9,592
Research and development	7,842	7,394	6,507	6,501	5,692	5,530	6,020	5,894	5,472	5,172
Operating income	9,650	8,869	8,121	10,381	8,565	7,579	6,802	6,024	7,273	7,518
EBIT	9,650	8,869	8,121	10,381	8,565	7,579	6,802	6,024	7,273	7,518
EBITDA	12,638	11,665	11,076	13,093	11,251	10,466	10,113	9,363	10,280	10,359
Interest expense	531	641	589	402	362	459	544	471	346	360
Pre-tax income	6,020	6,758	6,115	9,992	7,837	14,137	3,007	4,904	5,616	5,811
Income tax	1,043	1,204	1,017	1,909	1,558	1,807	121	481	1,722	1,325
Net income	7,813	5,560	5,400	8,371	6,223	12,294	2,754	4,306	8,416	4,709
Net income to common shareholders	4,939	5,496	5,062	7,970	6,223	12,294	2,855	4,319	3,773	4,395
Basic EPS	4.05	4.39	4.04	6.37	4.97	9.81	2.28	3.46	3.00	3.42
Diluted EPS	4.03	4.39	4.04	6.35	4.95	9.76	2.27	3.44	2.98	3.39
Average shares (basic)	1,220	1,251	1,252	1,252	1,253	1,254	1,250	1,247	1,257	1,287
Average shares (diluted)	1,226	1,256	1,256	1,257	1,258	1,260	1,257	1,255	1,267	1,296
Dividend per share	4.12	3.92	3.76	3.56	3.33	3.20	3.15	3.07	3.03	2.96